Breast cancer can be divided into the luminal A subtype, luminal B subtype, human epidermal growth factor receptor 2- (Her-2-) positive subtype, and triple-negative breast cancer (TNBC) subtype based on the molecular types. Here, ERBB2 is linked to triple-negative breast carcinoma.